Research Insight

Navigating Russia’s Compliance Regulations; Arguably the Most Complex in...

Russia’s increasing reliance on pharmaceutical-driven healthcare is resulting in a growing consumer demand for drugs of all types. Over the past few decades, the country’s domestic...

Lonza and AllCells Join Forces for Global Commercialization of...

Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells. ...

New Study Findings Show Mixture of DuPont Probiotic Strains...

New findings from a Giellepi Health Science Division clinical research trial demonstrates that a mixture of probiotic strains and lactoferrin could aid in reducing the...

WuXi AppTec Expands Site in California for Pharmaceutical R&D...

WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in...

Eisai and UCLommence preparations for phase i clinical studies...

Eisai Co., Ltd  and University College London   announced  that they have commenced preparations for Phase I clinical studies on E2814 The first...

ADC Bio secures additional equity round investment

ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing investors and company management. The investment syndicate...

Protagen AG collaborates with UCSF to study better immuno-profiling...

Protagen AG has announced the start of a collaboration with the University of California, San Francisco (UCSF) to utilize Protagen’s SeroTag® technology to investigate the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read